Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Until today this year the stock’s price performance recorded a decrease of -54.58%. However, over the last six months, the performance has been stronger
Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Matinas Biopharma Holdings Inc’s current trading price is -85.84% away from its 52-week high, while its distance from the 52-week
Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Matinas Biopharma Holdings Inc’s current trading price is -82.81% away from its 52-week high, while its distance from the 52-week low is
In terms of market performance, Matinas Biopharma Holdings Inc had a fairly uneven. The highest value for the stock in the past year was $0.89 on 10/11/23, and the lowest value was recorded at $0.11 on 08/10/23. 52-week price history of MTNB Stock A stock’s
The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Until today this year the stock’s price performance recorded a decrease of -13.60%. However, over the last six months,
A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Matinas Biopharma Holdings Inc’s current trading price is -81.28% away from its 52-week high, while its distance from the 52-week low is 51.04%. The
All rights reserved © 2024, Powered By Smart TechOne
